CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells

Immunology

Volumn 133, Issue 3, 2011, Pages 350-359

  Fu, Binqing ^a   Wang, Fuyan ^a   Sun, Rui ^a   Ling, Bin ^b   Tian, Zhigang ^a   Wei, Haiming ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

Cell development; Cellular immunology; Decidual natural killer cells; Human natural killer cells; Innate immunity

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN; CD34 ANTIGEN; CD94 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ARTICLE; CELL FUNCTION; CELL POPULATION; CELL SPECIFICITY; CYTOKINE RELEASE; CYTOSOL; DECIDUA; DEVELOPMENTAL STAGE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ANTIGENS, CD11B; ANTIGENS, CD27; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS;

EID: 79957789176     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03446.x     Document Type: Article

References (41)

1. Galy A, Travis M, Cen DZ, Chen B. Human T-cells, B-cells, natural-killer, and dendritic cells arise from a common bone-marrow progenitor-cell subset. Immunity 1995; 3:459-73.
2. + Nk progenitor. Blood 1994; 83:2594-601.
3. Shibuya A, Kojima H, Shibuya K, Nagayoshi K, Nagasawa T, Nakauchi H. Enrichment of interleukin-2-responsive natural-killer progenitors in human bone-marrow. Blood 1993; 81:1819-26.
4. Bright natural killer cells. Blood 2004; 104:93a-93a.
5. Freud AG, Yokohama A, Becknell B, Lee MT, Mao HC, Ferketich AK, Caligiuri MA. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med 2006; 203:1033-43.
6. Huntington ND, Vosshenrich CAJ, Di Santo JP. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 2007; 7:703-14.
7. Male V, Hughes T, McClory S, Colucci F, Caligiuri MA, Moffett A. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J Immunol 2010; 185:3913-8.
8. Hughes T, Becknell B, McClory S et al. Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 2009; 113:4008-10.
9. + lineage distinct from conventional natural killer cells. J Exp Med 2010; 207:281-90.
10. Hughes T, Becknell B, Freud AG et al. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 2010; 32:803-14.
11. Cella M, Fuchs A, Vermi W et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457:722-5.
12. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-40.
13. Caligiuri MA. Human natural killer cells. Blood 2008; 112:461-9.
14. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol 2003; 3:413-25.
15. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003; 101:3052-7.
16. Beziat V, Descours B, Parizot C, Debre P, Vieillard V. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE 2010; 5:e11966.
17. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006; 176:1517-24.
18. Vossen MT, Matmati M, Hertoghs KM et al. CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol 2008; 180:3739-45.
19. Hayakawa Y, Huntington ND, Nutt SL, Smyth MJ. Functional subsets of mouse natural killer cells. Immunol Rev 2006; 214:47-55.
20. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009; 113:5488-96.
21. Le Garff-Tavernier M et al. Human NK cells display major phenotypic and functional changes over the life span. Aging cell 2010; 9:527-35.
22. Allavena P, Bianchi G, Paganin C, Giardina G, Mantovani A. Regulation of adhesion and transendothelial migration of natural killer cells. Nat Immun 1996; 15:107-16.
23. Vivier E, Morin P, O'Brien C, Druker B, Schlossman SF, Anderson P. Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J Immunol 1991; 146:206-10.
24. Marcenaro S, Gallo F, Martini S, Santoro A, Griffiths GM, Arico M, Moretta L, Pende D. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 2006; 108:2316-23.
25. Xia Y, Borland G, Huang J, Mizukami IF, Petty HR, Todd RF, Ross GD. Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. J Immunol 2002; 169:6417-26.
26. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986; 136:4480-6.
27. Beziat V, Nguyen S, Lapusan S et al. Fully functional NK cells after unrelated cord blood transplantation. Leukemia 2009; 23:721-8.
28. low NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J Immunol 2008; 181:2227-37.
29. Nguyen S, Dhedin N, Vernant JP et al. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 2005; 105:4135-42.
30. Vago L, Forno B, Sormani MP et al. Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation. Blood 2008; 112:3488-99.
31. Verma S, Hiby SE, Loke YW, King A. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 2000; 62:959-68.
32. Koopman LA, Kopcow HD, Rybalov B et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198:1201-12.
33. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev 2006; 214:56-72.
34. Verma S, King A, Loke YW. Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur J Immunol 1997; 27:979-83.
35. Brodin P, Karre K, Hoglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 2009; 30:143-9.
36. Hanna J, Mandelboim O. When killers become helpers. Trends Immunol 2007; 28:201-6.
37. Karimi K, Blois SM, Arck PC. The upside of natural killers. Nat Med 2008; 14:1184-5.
38. Hanna J, Goldman-Wohl D, Hamani Y et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12:1065-74.
39. + cell-derived NK cell cytotoxicity by dendritic cells. J Immunol 2001; 166:1590-600.
40. Borg C, Jalil A, Laderach D et al. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004; 104:3267-75.
41. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007; 26:503-17.